S
sapheri
I have a procedure that dictates that in order for SQE to issue a SCAR to supplier the manufacturing team at my plant must prove that manufacturing process internally didn't damage the part and that the inherit design of part did not cause the nonconformance with the part.
From here once this has been proven SQE issues a SCAR and works with the supplier to determine how the NC occurred. Is this appropriate to ask for this initial/internal analysis prior to issuing a SCAR?
Problems have arose in the past were SQE opened SCARs with suppliers for every issue with a part that was supplied which resulted in increased time to close records and sometimes false accusations against suppliers.
In context I work in Medical Devices at ISO13485:2003 Certified Facility.
From here once this has been proven SQE issues a SCAR and works with the supplier to determine how the NC occurred. Is this appropriate to ask for this initial/internal analysis prior to issuing a SCAR?
Problems have arose in the past were SQE opened SCARs with suppliers for every issue with a part that was supplied which resulted in increased time to close records and sometimes false accusations against suppliers.
In context I work in Medical Devices at ISO13485:2003 Certified Facility.